NCT04704388

Brief Summary

To assess the proportion of post-intensive care syndrome (PICS) of patients who received high flow humidified oxygen with FiO2 ≥50% for more than 48h and / or who received mechanical ventilation for more than 48h in a context of hospitalization in intensive care for COVID-19 pneumonia

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
478

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2020

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2020

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

January 7, 2021

Completed
4 days until next milestone

First Posted

Study publicly available on registry

January 11, 2021

Completed
Last Updated

April 1, 2021

Status Verified

March 1, 2021

Enrollment Period

4 months

First QC Date

January 7, 2021

Last Update Submit

March 26, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • post-intensive care syndrome (PICS)

    To assess the proportion of post-intensive care syndrome (PICS) of patients who received high flow humidified oxygen with FiO2 ≥50% for more than 48h and / or who received mechanical ventilation for more than 48h in a context of hospitalization in intensive care for COVID-19 pneumonia.

    3 month after hospitalisation

Secondary Outcomes (3)

  • Evaluate the 3-month mortality of patients released alive from intensive care

    3 month after end of hospitalisation

  • Describe the overall state of health and the main organ sequelae of these patients

    3 month after hospitalisation

  • functional respiratory sequelae

    3 month after hospitalisation

Study Arms (2)

patients hospitalized in intensive care units for SARS-CoV-2

patients hospitalized in intensive care units for SARS-CoV-2

patients hospitalized outside intensive care units

patients hospitalized outside intensive care units

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Paitent admitted between March 1 and May 10, 2020 in Bicêtre hospital for an infection with SARS-CoV-2

You may qualify if:

  • Group 1: patients hospitalized in intensive care units for ARDS with SARS-CoV-2
  • Major
  • Admitted between March 1 and May 10, 2020 in one of the sectors of the Bicêtre hospital approved for critical care
  • proven SARS-CoV-2 infection
  • Treated by invasive mechanical ventilation or high flow humidified oxygen with FiO2 ≥50% for more than 48 hours.
  • Group 2: patients hospitalized outside intensive care units
  • Major
  • Admitted between March 1 and May 10, 2020 in an area of Bicêtre hospital having cared for patients infected with SARS-CoV-2 excluding critical care: pulmonology, internal medicine / orthopedics, infectious diseases, nephrology , acute geriatrics, neurology.

You may not qualify if:

  • Patients having refused the post consultation at 3 month
  • Without social security coverage

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bicêtre Hospital

Le Kremlin-Bicêtre, 94270, France

Location

Related Publications (1)

  • Pham T, Morin L, Savale L, Colle R, Figueiredo S, Harrois A, Gasnier M, Lecoq AL, Meyrignac O, Noel N, Abdo A, Baudry E, Bellin MF, Beurnier A, Choucha W, Corruble E, Dortet L, Gosset E, Hardy-Leger I, Quinque M, Radiguer F, Sportouch S, Verny C, Wyplosz B, Zaidan M, Becquemont L, Montani D, Monnet X. Four- and sixteen-month clinical status of a cohort of patients following hospitalization for COVID-19. Respir Med Res. 2024 Nov;86:101099. doi: 10.1016/j.resmer.2024.101099. Epub 2024 Mar 4.

MeSH Terms

Conditions

COVID-19

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Study Officials

  • Tài PHAM

    APHP

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 7, 2021

First Posted

January 11, 2021

Study Start

June 1, 2020

Primary Completion

October 1, 2020

Study Completion

October 1, 2020

Last Updated

April 1, 2021

Record last verified: 2021-03

Data Sharing

IPD Sharing
Will not share

Locations